Humira biosimilars set the stage for long-awaited 2023 US launches
Pharmaceutical Technology
DECEMBER 4, 2022
Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market.
Pharmaceutical Technology
DECEMBER 4, 2022
Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market.
Pharma Phorum
DECEMBER 4, 2022
Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
DECEMBER 4, 2022
Whether a job search is voluntary or not, the psychological toll of months of interviews, wrangling over pay and benefits and evaluating options has a weighty psychological toll
Pharma Phorum
DECEMBER 4, 2022
Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities.
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
BioSpace
DECEMBER 4, 2022
FUJIFILM Diosynth Biotechnologies is offering unique opportunities to join one of the top global CDMOs focused on solving some of the most complex healthcare challenges
Pharma Phorum
DECEMBER 4, 2022
Amgen and Sanofi have said they may make cash-only offers for Horizon Therapeutics, which confirmed it was in talks with potential buyers last week, but Johnson & Johnson has ruled itself out of the running.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Phorum
DECEMBER 4, 2022
Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2 programme for the drug next year.
BioSpace
DECEMBER 4, 2022
Monday, Verve Therapeutics revealed that the FDA has officially requested several buckets of additional safety information to lift the hold on its lead candidate, VERVE-101
Drug Patent Watch
DECEMBER 4, 2022
Annual Drug Patent Expirations for VIIBRYD Viibryd is a drug marketed by Allergan and is included in one NDA. It is available from four suppliers. There are four patents protecting…. The post New patent expiration for Allergan drug VIIBRYD appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
DECEMBER 4, 2022
Janssen (Johnson & Johnson) is no longer in the running to acquire rare disease player Horizon Therapeutics, the company announced Saturday. This leaves Amgen and Sanofi at the bidding table
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Drug Patent Watch
DECEMBER 4, 2022
[ conference in San Francisco, CA
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
JAMA Internal Medicine
DECEMBER 4, 2022
This systematic review and meta-analysis investigates whether female participants and racial and ethnic minority individuals are adequately represented in COVID-19 prevention and treatment trials in the US
Drug Patent Watch
DECEMBER 4, 2022
This chart shows the drugs with the most patents in Eurasian Patent Organization. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical drugs have the most drug patents in Eurasian Patent Organization? appeared first on DrugPatentWatch - Make Better Decisions. Infographic
JAMA Internal Medicine
DECEMBER 4, 2022
This cluster randomized controlled trial assesses whether abandoned house remediation reduces gun violence and substance-related outcomes and increases perceptions of safety and use of outdoor space in low-income, Black neighborhoods
JAMA Internal Medicine
DECEMBER 4, 2022
This randomized clinical trial examines the effects of 2 financial incentive strategies among patients with obesity living in low-income neighborhoods
JAMA Internal Medicine
DECEMBER 4, 2022
This cohort study examines the association of 13-valent pneumococcal conjugate vaccine use with pneumonia, non–health care–associated pneumonia, and lobar pneumonia (LP) hospitalization among US Medicare beneficiaries 65 years or older
Let's personalize your content